Niue Health Report: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Niue Health Report.

Press releases published on June 3, 2026

10 hours ago

Spyre Therapeutics Announces Completion of Enrollment in SKYWAY Basket Trial Evaluating SPY072 (anti-TL1A) in RA, PsA, and axSpA

Indeterminate GlobeNewswire

10 hours ago

Biomea Fusion Announces Research Collaboration with University of Leicester to Evaluate Icovamenib in Combination with Semaglutide in Obesity

Indeterminate GlobeNewswire

10 hours ago

Konica Minolta Healthcare Expands Service Offerings and Updates AeroRemote Insights with In-Depth Analytics and Operational Intelligence to Help Facilities Address Current Department Challenges

Indeterminate GlobeNewswire

10 hours ago

Kyverna Therapeutics Highlights Updated Miv-cel Data at EULAR Demonstrating Substantial Reduction in Disease Activity in ACPA-Positive, Treatment Refractory Rheumatoid Arthritis

Indeterminate GlobeNewswire

10 hours ago

Denovo to Participate in Upcoming Investor Conferences Highlighting its Biomarker Guided Phase 3 Antidepressant

Indeterminate GlobeNewswire

10 hours ago

Celularity Appoints Rick Gonzalez as Chief Commercial Officer

Indeterminate GlobeNewswire

10 hours ago

Noah Medical Appoints Dr. Krish Bhadra as Chief Pulmonary Advisor

Indeterminate GlobeNewswire

10 hours ago

New Expert Consensus Provides Age-Specific Guidance for Improving Care for Individuals with Genital Psoriasis Published in the American Journal of Clinical Dermatology

Indeterminate GlobeNewswire

10 hours ago

RadNet Announces a Proposed $200 Million Incremental Term Loan to Fund Strategic Growth Opportunities

Indeterminate GlobeNewswire

10 hours ago

Angelini Ventures Marks First Portfolio Company Exit as ResMed Acquires Noctrix Health for $340 million

Indeterminate GlobeNewswire

10 hours ago

Biogen Announces Upcoming Kidney Presentations at European Renal Association and American Transplant Congresses

Indeterminate GlobeNewswire

10 hours ago

Dyne Therapeutics Announces Completion of Enrollment in Registrational Expansion Cohort of ACHIEVE Trial of Z-Basivarsen for Myotonic Dystrophy Type 1 (DM1)

Indeterminate GlobeNewswire

10 hours ago

TG Therapeutics Announces Positive Results from Phase 1 Trial Evaluating Subcutaneous BRIUMVI® (ublituximab-xiiy)

Indeterminate GlobeNewswire

10 hours ago

Palvella Therapeutics Announces Completion of FDA Pre-NDA Meeting for QTORIN™ Rapamycin in Microcystic Lymphatic Malformations

Indeterminate GlobeNewswire

10 hours ago

Celcuity Inc. Announces Public Offering of Convertible Senior Notes Due 2032

Indeterminate GlobeNewswire

11 hours ago

Mammogen Secures Up to $30 Million Series A Financing Backed by Leading U.S. Public Retirement System to Advance Blood-Based RNA Breast Cancer Detection Platform

Indeterminate GlobeNewswire

11 hours ago

Invivyd Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

11 hours ago

SweetWater Brewing Unveils Atlanta-Wide Soccer Celebration as Global Fans Descend on the City This Summer

Indeterminate GlobeNewswire

11 hours ago

Ovid Therapeutics Appoints Leading Physician-Scientist and Biotech Innovator Anna Greka, M.D., Ph.D., to Board of Directors

Indeterminate GlobeNewswire

11 hours ago

Cabaletta Bio Announces New Rese-cel Data and Development Updates Across Autoimmune Portfolio, Including Encouraging Early PC-Free Lupus Findings, at EULAR 2026 Congress

Indeterminate GlobeNewswire